Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × Amyloidosis × Clear all

Phase

Status

Completed 3 Unknown 1

Sponsor Class

OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Leukemia, Myeloid, Acute 12 Colorectal Neoplasms 10 Rectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Head and Neck Neoplasms 6 Fallopian Tube Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Leukemia 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Vulvar Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Fatigue 3 Depression 3 Central Nervous System Neoplasms 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Stress Disorders, Post-Traumatic 2 Rhabdomyosarcoma 2 Oligodendroglioma 2

Interventions

pomalidomide 1 isatuximab 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡